Ultrasound to put an end to diabetes with the help of artificial intelligence
Spanish doctor Eduardo Jorgensen has created a device that can predict the amount of insulin needed by its user thanks to artificial intelligence and administer it without any need for needles.
More than 422 million people worldwide are diabetic, according to the first Global Report on Diabetes published by WHO. A diabetic´s body cannot adequately control blood sugar levels and treatment involves the use of needles to administer a hormone when they notice their body is not responding. An inconvenient and tiresome process that requires one to always be vigilant and that not everyone is willing to put up with. This is what happened to a young diabetic girl, who one day in Eduardo Jorgensen´s clinic rejected this treatment. This patient´s situation did not seem fair to Jorgensen so he started to work on the development of MedicSen, a device that functions as an artificial pancreas and treats the diabetes in a personalized, preemptive and needle-free way.
Coming from a family of doctors, the young Spaniard wanted to orientate his career towards neurosurgery. However, while finishing his studies, he met this patient. The young girl made him reconsider his path. According to him, existing technology for treating diabetes is inadequate and in 2014, he founded MedicSensors. Through this company he developed this system consisting of two parts: a smart algorithm connected to an app that communicates with the user and a skin patch, that releases the insulin the body needs.
The MedicSen algorithm registers and analyses information from the wearables worn by the user in real-time, just like a watch or a bracelet. With this monitoring, the device creates behavior patterns and prevents potential risks. It is able to predict glucose levels that the user will have in the future according to the actions performed, such as having a soda or going for a half-an-hour run. With all this information, the algorithm can also calculate the amount of insulin the patient needs. Afterwards, it sends a signal to the patch which administers the dose automatically and painlessly through ultrasound. Furthermore, the patient can be aware of their status at all times as the app notifies them of their glucose levels and recommends daily habits.
Currently, Jorgensen, who has been selected as Innovator under 35, Europe 2017 and recognized as Innovator of the Year in Spain by MIT Technolgy Review in Spanish, continues to develop this system and is undertaking the necessary tests to demonstrate its efficiency in human beings. His objective is to obtain permission so that MedicSen can be on the market by 2019.
Although the main application of this technology is focused on improving the lives of diabetics, its impact could be even greater. In the future, this system could be modified to treat other chronic diseases that require both a continuous administration of medicine and monitoring. The Jorgensen system occupies its space in a new panorama of health, based on the prevention of diseases with the help of the analysis and interpreting of data generated on a daily basis. We are heading for the era of preventive and personalized digital medicine.